Prescient Therapeutics Ltd

NEW
ASX:PTX (Australia)  
A$ 0.076 -0.0035 (-4.38%) Jul 15
At Loss
P/B:
4.78
Market Cap:
A$ 84.12M ($ 58.75M)
Enterprise V:
A$ 74.63M ($ 52.12M)
Volume:
468.83K
Avg Vol (2M):
945.13K
Trade In:
Volume:
468.83K
At Loss
Avg Vol (2M):
945.13K

Prescient Therapeutics Ltd (ASX:PTX) Dividend

Prescient Therapeutics Ltd (ASX:PTX) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -7.2%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ASX:PTX Dividend

Does Prescient Therapeutics Ltd (ASX:PTX) pay a dividend?

Prescient Therapeutics Ltd (ASX:PTX) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Prescient Therapeutics Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Prescient Therapeutics Ltd has returned capital to shareholders via buybacks at a rate of -7.2% over the past 3 years.

What are dividend-paying alternatives to Prescient Therapeutics Ltd?

For dividend-paying alternatives in Prescient Therapeutics Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.